Immune recovery and immunotherapy after stem cell transplantation in children

Bone Marrow Transplantation

Volumn 28, Issue , 2001, Pages S14-S15

  Vossen, J M ^a   Handgretinger, R ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD19 ANTIGEN; CD45 ANTIGEN; EPITOPE; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BLAST CELL; CANCER RECURRENCE; CELL KILLING; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DONOR; HLA MATCHING; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOREACTIVITY; IMMUNOTHERAPY; IN VITRO STUDY; INFECTION RISK; LONGITUDINAL STUDY; LYMPHOID CELL; MEMORY CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RECIPIENT; SIBLING; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOTHERAPY; LEUKEMIA; LONGITUDINAL STUDIES; LYMPHOID TISSUE; RECURRENCE;

EID: 0034824206     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703170     Document Type: Article

References (9)

1. Bacigalupo A, Mordini N, Pitto A et al: Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. Br J Haematol 1997; 98:760-766.
2. Goldman JM, Gale RP, Horowitz MM, et al: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108:806-814.
3. Oudshoom M, Comelissen JJ, Fibbe WE, et al: Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997; 20:1011-1017.
4. Ruggeri L, Capanni M, Casucci M, et al: Role of natural killer alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94:333-339.
5. Hauch M, Gazzola MV, Small T, et al: Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 1990; 75:2250-2262.
6. Soiffer RJ, Murray C, Gonin R, et al: Effect of low-dose interleukin-2 on disease relapse fter T-cell depleted allogeneic bone marrow transplantation. Blood 1994;84:964-971
7. Kolb HJ, Mittermüller J, Clemm Ch, et al: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76:2462-2465
8. Goulmy E: Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157:125-140.
9. Mutis T, Verdijk R, Schrama E, et al: Feasibility of immunotherapy of relapsed leukemia with ex-vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93:2336-2341